Anxiety vs Stress: What Is the Difference?

What stress and anxiety actually are at a physiological level

Stress is your body's response to a demand. A work presentation, a financial strain, a sick family member. The stressor is identifiable, and the physiological response is proportional. Your hypothalamic-pituitary-adrenal (HPA) axis activates, cortisol rises, your sympathetic nervous system kicks in, and your body mobilizes resources to meet the challenge. When the stressor resolves, the system is designed to return to baseline.

Anxiety, by contrast, is a state of heightened threat perception that persists independent of external circumstances. It can emerge in the absence of any identifiable stressor, or it can be disproportionate to the situation at hand. The same HPA axis and sympathetic pathways activate, but they don't shut off cleanly.

The amygdala, your brain's threat-detection center, becomes hyperreactive. The prefrontal cortex, which normally regulates emotional responses and assesses whether a threat is real, shows reduced activity. This creates a feedback loop where the brain interprets ambiguous or neutral situations as dangerous, sustaining the physiological state of alarm even when there's nothing to be alarmed about. The distinction isn't just semantic: stress is adaptive when it's acute and proportional, while anxiety becomes maladaptive when the protective system starts firing without cause.

How stress and anxiety affect the nervous system, hormones, and brain

Autonomic nervous system patterns

Both stress and anxiety activate the autonomic nervous system, but the pattern and duration differ. In a typical stress response, the sympathetic nervous system ramps up: heart rate increases, blood pressure rises, glucose is released into the bloodstream, and non-essential functions like digestion slow down. Once the stressor is gone, the parasympathetic nervous system takes over, restoring balance.

In anxiety, the sympathetic nervous system remains partially activated even at rest. Heart rate variability (HRV), a measure of the balance between sympathetic and parasympathetic tone, tends to be lower in people with anxiety disorders. This reflects a nervous system that's chronically primed for threat, with less capacity to downregulate. The vagus nerve, which mediates parasympathetic recovery, shows reduced tone in anxiety states.

Cortisol dynamics

Acute stress produces a sharp cortisol spike that resolves within hours. Chronic stress can lead to sustained elevation or, eventually, a blunted cortisol response as the HPA axis becomes dysregulated. Anxiety disorders often show a different pattern: flattened diurnal cortisol rhythms, where the normal morning peak and evening decline are less pronounced, or heightened cortisol reactivity to minor stressors. Some individuals with long-standing anxiety show paradoxically low cortisol, a sign that the HPA axis has been overworked to the point of exhaustion.

Brain structure and function

Anxiety is associated with structural and functional changes in the brain. The amygdala, which processes fear and threat, is often enlarged and hyperactive in anxiety disorders. The hippocampus, involved in memory and context processing, may be smaller, impairing the brain's ability to distinguish between past threats and present safety.

The prefrontal cortex, responsible for rational thought and emotional regulation, shows reduced connectivity with the amygdala, meaning the "brake" on fear responses doesn't work as effectively. These changes don't happen with short-term stress. They develop with prolonged or repeated activation of the anxiety circuitry.

What drives stress vs what sustains anxiety

Stress is driven by external demands: workload, relationship conflict, financial pressure, caregiving responsibilities, illness. The input is identifiable, and addressing the stressor typically reduces the physiological response. If you finish the project, the stress resolves. If you resolve the conflict, your cortisol drops.

Anxiety is sustained by internal processes. Cognitive patterns play a central role. Catastrophic thinking, where the mind jumps to worst-case scenarios, keeps the threat system activated. Rumination, the repetitive focus on potential dangers or past mistakes, prolongs cortisol elevation and prevents the nervous system from downregulating. Intolerance of uncertainty, a hallmark of many anxiety disorders, means that ambiguous situations are interpreted as threatening by default.

Sleep disruption is both a symptom and a driver of anxiety. Poor sleep impairs prefrontal cortex function, reducing the brain's ability to regulate emotional responses. It also increases amygdala reactivity, making neutral stimuli feel more threatening. Chronic sleep deprivation elevates baseline cortisol and inflammatory markers, creating a physiological environment that sustains anxiety even in the absence of external stressors.

Nutritional factors also matter:

• Low magnesium is associated with increased anxiety and HPA axis dysregulation.
• Omega-3 deficiency is linked to neuroinflammation and reduced serotonin signaling.
• Blood sugar instability causes fluctuations in cortisol and adrenaline that mimic and exacerbate anxiety symptoms.
• Gut microbiome imbalances reduce production of gamma-aminobutyric acid (GABA), the brain's primary inhibitory neurotransmitter, and increase production of inflammatory metabolites that affect brain function.

Genetics and early life experience shape vulnerability. Polymorphisms in genes affecting serotonin transport, cortisol receptor sensitivity, and GABA receptor function influence baseline anxiety levels and stress reactivity. Adverse childhood experiences recalibrate the HPA axis, often leading to heightened threat sensitivity and a lower threshold for anxiety activation in adulthood. This is allostatic load: the cumulative wear on stress-regulating systems from repeated or prolonged activation.

Why the same situation produces stress in one person and anxiety in another

Two people face the same deadline. One experiences stress: elevated cortisol, focused attention, a sense of urgency that resolves when the task is complete. The other experiences anxiety: racing thoughts, physical tension, catastrophic predictions about failure, and symptoms that persist even after the deadline passes. The external stressor is identical. The internal response is not.

Baseline autonomic tone is one factor. Individuals with higher resting HRV and stronger vagal tone recover from stressors more quickly and are less likely to develop sustained anxiety. Those with lower HRV and weaker parasympathetic function remain in a state of heightened arousal longer.

Cognitive style matters. People prone to anxiety tend to have a lower threshold for perceiving threat, a tendency to overestimate the likelihood of negative outcomes, and difficulty disengaging attention from potential dangers. This isn't a character flaw; it reflects differences in how the prefrontal cortex and amygdala communicate. Neuroimaging studies show that individuals with anxiety disorders have reduced prefrontal inhibition of the amygdala.

Hormonal context also plays a role:

• Estrogen and progesterone fluctuations across the menstrual cycle affect GABA receptor sensitivity and serotonin signaling, which is why some women experience heightened anxiety premenstrually or during perimenopause.
• Thyroid dysfunction, even subclinical hypothyroidism, can present as anxiety due to its effects on metabolism and neurotransmitter synthesis.
• Low testosterone in men is associated with increased anxiety and reduced stress resilience.

History of prior anxiety episodes lowers the threshold for future ones. Once the anxiety circuitry has been strongly activated, it becomes easier to reactivate. This is a form of neuroplasticity: the brain gets better at what it practices, including anxiety. Individuals with a history of panic attacks, for example, may develop heightened interoceptive awareness, where normal physiological sensations like a faster heartbeat are interpreted as signs of danger.

What the research shows about when stress becomes anxiety

The transition from stress to anxiety isn't arbitrary. Diagnostic criteria distinguish between normal stress responses and anxiety disorders based on duration, intensity, and functional impairment:

• Generalized anxiety disorder (GAD) is diagnosed when excessive worry occurs more days than not for at least six months, is difficult to control, and is accompanied by physical symptoms like muscle tension, fatigue, or sleep disturbance.
• Panic disorder involves recurrent, unexpected panic attacks and persistent concern about future attacks.
• Social anxiety disorder is marked by intense fear of social situations where scrutiny is possible, leading to avoidance that impairs daily functioning.

Research distinguishes acute stress from chronic stress and both from anxiety disorders. Acute stress produces transient HPA axis activation and resolves within hours to days. Chronic stress involves sustained or repeated activation over weeks to months, leading to HPA axis dysregulation but typically without the cognitive and neurological features of anxiety disorders. Anxiety disorders involve not just prolonged physiological activation but also maladaptive cognitive patterns, structural brain changes, and impairment in multiple life domains.

Longitudinal studies show that chronic stress is a risk factor for developing anxiety disorders, but not everyone with chronic stress develops anxiety. Protective factors include strong social support, which buffers cortisol reactivity and reduces inflammatory signaling; regular physical activity, which increases brain-derived neurotrophic factor (BDNF) and improves HRV; and cognitive flexibility, the ability to reframe situations and disengage from rumination.

Interventions that work for stress don't always work for anxiety. Stress management focuses on reducing external demands, improving time management, and enhancing recovery through sleep and relaxation. These help with anxiety too, but they're often insufficient. Anxiety disorders typically require interventions that target the underlying cognitive and neurological patterns: cognitive-behavioral therapy (CBT) to restructure catastrophic thinking, exposure therapy to recalibrate threat perception, and in some cases, medication to modulate serotonin, GABA, or norepinephrine signaling. The evidence for CBT in anxiety disorders is robust, with effect sizes comparable to or exceeding those of pharmacotherapy in many cases.

How to measure where your stress and anxiety actually stand

Subjective experience alone doesn't distinguish stress from anxiety. Both feel overwhelming. Both produce physical symptoms. Objective markers provide a clearer picture.

Cortisol measurement, ideally via four-point salivary cortisol testing, reveals diurnal rhythm patterns. A normal pattern shows a sharp morning peak, gradual decline through the day, and low evening levels. Chronic stress may show sustained elevation or a flattened curve. Anxiety disorders often show blunted morning cortisol or erratic patterns that don't follow the expected rhythm. DHEA-S, a counter-regulatory hormone to cortisol, provides additional context; a low cortisol-to-DHEA-S ratio suggests HPA axis exhaustion.

Heart rate variability (HRV) is one of the most accessible real-time measures of autonomic balance. Lower HRV indicates reduced parasympathetic tone and a nervous system that's less able to recover from stress. Tracking HRV over time shows whether interventions are improving autonomic regulation or whether the system remains stuck in a state of heightened arousal.

Inflammatory markers like high-sensitivity C-reactive protein (hs-CRP) are relevant because chronic stress and anxiety both drive low-grade inflammation, which in turn affects mood and cognitive function. Elevated hs-CRP in the absence of infection or injury suggests that stress or anxiety is affecting immune regulation.

Thyroid function is worth checking because thyroid dysfunction mimics anxiety. TSH, free T3, and free T4 should all be within healthy ranges, not just "normal." Subclinical hypothyroidism, where TSH is elevated but thyroid hormones are still in range, commonly presents with anxiety, fatigue, and brain fog.

Nutrient status affects both stress resilience and anxiety:

• Magnesium, ideally measured as RBC magnesium rather than serum, is critical for HPA axis regulation and GABA receptor function.
• Vitamin B12 and folate are necessary for neurotransmitter synthesis.
• Ferritin, a marker of iron stores, is often low in people with anxiety and fatigue; low ferritin impairs dopamine and serotonin production.
• Vitamin D affects mood regulation and immune function, and deficiency is associated with increased anxiety.

Tracking these markers over time, alongside subjective measures like symptom frequency and functional impairment, provides a physiological narrative that clarifies whether you're dealing with a stress response that needs better recovery or an anxiety pattern that requires more targeted intervention.

Getting objective about the difference

If you're dealing with persistent worry, physical tension, or a sense of dread that doesn't resolve when external pressures ease, the distinction between stress and anxiety isn't academic. It determines what you're actually addressing. Superpower's 100+ biomarker panel gives you a baseline across cortisol patterns, thyroid function, inflammatory markers, and nutrient status that routine bloodwork does not always include. Pair that with HRV tracking, and you have a data-driven foundation for understanding whether your nervous system is responding to real demands or stuck in a state of heightened threat perception that needs a different approach.